Introduction
Coccidiostats belong to the group of pharmacologically active substances which are used as feed additives to prevent coccidiosis in poultry and rabbits, and also as a medicine for the treatment of coccidiosis in food producing animals. In commercial production, the main method of controlling coccidiosis is addition of coccidiostats to the feed at authorised levels and observation of the prescribed hygiene requirements. Maduramycin ( Figure 1 ) is a polyether ionophoric coccidiostat produced by moulds Actinomadura yumaensis authorised to be used to prevent coccidiosis in fattening chickens and turkeys (max. 16 weeks). It is added to the feed in the form of ammonium salt at a minimum/maximum content of active substance in complete feed of 5 mg. Insert " Figure 1 " around here.
The residues of pharmacologically active substances in products of animal origin should be carefully monitored and controlled in accordance with the Council Directive 96/23/EC of 29
April, 1996, on measures to monitor certain substances and residues thereof in live animals and animal products (EC 1996) . Several analytical approaches have been used to determine the coccidiostat residues in different biological matrices, however, those methods were suitable for determination of one or more coccidiostats only. Because maduramycin does not possess a useful chromophore, there was a serious lack of suitable methods for its determination in the past. An enzyme-linked immunosorbent assay (ELISA) methods were initially developed to detect maduramycin residues in poultry. Kennedy et al. (1997) developed an ELISA method for determination of the depletion kinetics of maduramycin residues in poultry using polyclonal antibodies. This method had a LOD of approximately 0.02 ng.g -1 in tissue (ng.ml -1 in serum) and a LOQ of 1.0 ng.g -1 in tissue (ng.ml -1 in serum).
The authors reported that the antibodies exhibited minimal cross-reactivity with structurally similar ionophoric coccidiostats. Shen et al. (2001) developed ELISA based on immunoaffinity chromatography cleanup procedure for the analysis of maduramycin in broiler chicken tissues. The limits of detection were 1.0 ng.g -1 in muscle, 2.8 ng.g -1 in liver, and 1.5 ng.g -1 in fat.
Another approach of maduramycin detection is modification of maduramycin with a suitable reagent to obtain an ultraviolet (UV) absorbing product. Quantitative analysis was carried out using a combination of derivatisation procedure and LC separation technique 
Materials and methods

Experimental animals and pre-preparation of the samples
Fifteen 17-day old broiler chickens (hybrid Ross) with average weight of 0.510 ± 0.032 kg were used in our experiment. The broiler chickens were randomly divided into two groups, an experimental group (n = 12) fed the commercially-produced feed HYD-02-NORM-TYP containing 5 mg.kg -1 of maduramycin in complete feed and a control group (n = 3) fed unmedicated feed HYD-03-NORM-TYP. All broiler chickens had free access to feed and water. The chickens in experimental group were treated in this way until they were 40 days old. On this day (day 0 of the WP), two chickens were slaughtered and the respective samples 
Chemicals and reagents
Methanol gradient grade, acetonitrile gradient grade and glacial acetic acid pro analysis were purchased from Merck (Germany). Water was purified by reverse osmosis and deionized by
Milli-Q Plus system (Millipore, France). The standard of maduramycin was obtained from
Chemos-group (American Cyanamid Company, USA). Standard stock solution (0.5 mg.ml -1 ) and working standard solutions (2, 5, 10, 20, 30, 40 , 60 ng.ml -1 ) were prepared in methanol.
Stability of stock solution is 6 months when stored under refrigeration at -18ºC. Working solutions were prepared fresh prior to use.
Sample preparation
Homogenised sample (2 g) and acetonitrile (10 ml) in a centrifuge tube were placed in an ultrasonic bath for 15 min. Then the tubes were shaken for 30 min on a horizontal shaker and centrifuged for 10 min at 4°C at 3000 r.p.m. The acetonitrile extract was dried under the stream of nitrogen at 55°C and re-dissolved in 5 ml of deionised water. The supernatant was purified using a solid phase extraction (SPE, Strata-X, 200 mg, 6 ml, Phenomenex, USA). Before loading the sample onto a column, the column was conditioned with 3 ml of methanol followed by 3 ml of deionised water. The re-dissolved sample extract was passed through the conditioned column by gravity. The column was then washed with 3 ml of deionised water and dried under vacuum for 5 min. Maduramycin was eluted from column with 5 ml of methanol and eluate was concentrated to 1 ml using nitrogen flow at 40°C in TurboVap (Zymark, Swiss). Concentrated eluate was filtered using 0.2 µm syringe filter (Whatman, England) into an autosampler vial. Samples were cooled before analysis to 10 ºC. 
Matrix spiking
LC-MS/MS analysis
Maduramycin was analysed employing a Waters Alliance 2695 liquid chromatograph (Waters Co., Ireland) connected to the MicroMass Quattro Micro triple-quadrupole mass spectrometer (MicroMass Ltd., UK). Electrospray data were acquired using Mass Lynx software and the instrument was operated in a positive-ion mode. High performance liquid chromatography (HPLC) separation was performed on an analytical column Luna C 18 150x2 mm, particle size 3 µm (Phenomenex, USA), at 40ºC. The mobile phase was methanol/deionised water/glacial acetic acid 900/99/1 v/v/v delivered at a flow rate of 400 µl.min 
Method validation
The following validation parameters were determined: linearity, LOD, LOQ, decision limit (CCα), detection capability (CCβ), recovery, specificity, repeatability and robustness. The linearity of the LC-MS/MS response was proved with 8 calibration points in the concentration range of 0-60 ng.ml -1 (working standard solutions including zero concentration). With each set of investigated samples, the new calibration curve was made. The determination coefficients (R 2 ) of the standard calibration curves were at least 0.99 (Figure 3) . The LOD and No interferences between these compounds were detected. Repeatability was checked by using six muscle tissues fortified with 100 µg.kg -1 of maduramycin. The coefficient of variation was 14.2 %. Robustness of the method was investigated by checking the influence of the following parameters on the results: the volume of acetonitrile used for the extraction, the volume of methanol used for the elution from the SPE column, the flow rate of mobile phase, the desolvation temperature, nebuliser gas flow rate, cone voltage and collision voltage.
Insert " Figure 3 " around here.
Results and discussion
The mean residue concentrations of maduramycin (µg.kg -1 ) determined in respective chicken tissues, not corrected for recovery, and the standard deviations (SD) of measurements are presented in Table 1 . No residues of maduramycin were detected in the tissues from the control group (Figure 4 ).
Insert " Figure 4 " around here.
Insert " Table 1 " around here.
According to Table 1 , detectable residues of maduramycin were found in all examined matrices throughout the withdrawal period. The hearth contained the highest residue concentrations ranging from 285.8 ± 24.7µg.kg -1 (day 1 of the WP) to 223.5 ± 5.7 µg.kg -1 (day 5 of the WP). This agrees with the toxicological studies which reported that the primary target Insert " Figure 5 " around here.
Because no MRL has been established for maduramycin in edible chicken tissues, our evaluations regarding the food safety issue were based on MRL of 400 µg.kg -1 -500 µg.kg -1 established for maduramycin in some countries of the world (USA, Canada, Japan). Our results demonstrate that maduramycin at 5 mg.kg -1 of complete feed did not induce residues in the tissues of broiler chickens exceeding the non-EU established MRL. However, detectable residues of maduramycin on the last day of the WP allowed us to state that the establishment of EU MRL for maduramycin in chicken tissues helps to reduce the risk to consumer's health from the ingestion of maduramycin residues in broiler chickens and thus protects the health of consumers.
Insert " Figure 6 " around here.
It is interesting that we failed to observe a gradual decline in residual concentrations of maduramycin during the WP as can be seen in Figure 6 . The maduramycin tissue residue levels on the last day of the WP were several times higher than the LOD of the method. study showed that maduramycin residues in all examined samples on the last day of the WP were several times higher. A 5-day withdrawal period for maduramycin should ensure decline of its residues in the tissues of broiler chickens before slaughter to the levels that present no risk to the consumers. This raises a question whether the edible chicken tissues are really free from maduramycin residues after the 5-day withdrawal period has elapsed, especially considering the fact that the present instrumental technique is able to detect the residues at the levels of 10 -9 . Liquid chromatography coupled with mass spectrometry detection is one of the most powerful analytical tools in residue analysis and, as seen in our study, seems to be a suitable technique for monitoring of maduramycin residues also in edible tissue of broiler chickens.
Conclusions
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